Ganitumab with either exemestane or fulvestrant for postmenopausal women with advanced, hormone-receptor-positive breast cancer: a randomised, controlled, double-blind, phase 2 trial
Titel:
Ganitumab with either exemestane or fulvestrant for postmenopausal women with advanced, hormone-receptor-positive breast cancer: a randomised, controlled, double-blind, phase 2 trial
Auteur:
Robertson, John FR Ferrero, Jean-Marc Bourgeois, Hugues Kennecke, Hagen de Boer, Richard H Jacot, William McGreivy, Jesse Suzuki, Samuel Zhu, Min McCaffery, Ian Loh, Elwyn Gansert, Jennifer L Kaufman, Peter A